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We used single cell sequencing technology to characterize the transcriptomes of 1,174 human embryonic
stem cell-derived retinal ganglion cells (RGCs) at the single cell level. The human embryonic stem cell line
BRN3B-mCherry (A81-H7), was differentiated to RGCs using a guided differentiation approach. Cells were
harvested at day 36 and prepared for single cell RNA sequencing. Our data indicates the presence of three
distinct subpopulations of cells, with various degrees of maturity. One cluster of 288 cells showed increased
expression of genes involved in axon guidance together with semaphorin interactions, cell-extracellular
matrix interactions and ECM proteoglycans, suggestive of a more mature RGC phenotype.
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Background & Summary
Since the isolation of embryonic stem cells (ESCs)1–4 and generation of induced pluripotent stem cells
(iPSCs)5,6, pluripotent stem cells (PSCs) have made a tremendous contribution towards improving our
understanding of mechanisms involved in development and disease. PSCs have the ability to self-renew
and differentiate into all cell types of the body, thereby providing great potential for regenerative
medicine and cell replacement therapies. Further, PSC-derived progeny allow the investigation of disease-
affected cell types that are not readily accessible due to their anatomical location, such as retinal cells7–9.
Utilising such disease-affected cells will also signiﬁcantly improve the drug development pipeline through
efﬁcacy proﬁling and side effect or toxicity assessment10.
The development of RNA sequencing (RNA-seq) technology has allowed for the rapid quantiﬁcation
of individual gene transcripts. Integrating this high-throughput data with computational and statistical
methods provides a toolbox to study the molecular functions of human tissues. Critically, to date, the
majority of RNA-seq studies have been conducted on ‘bulk’ samples, consisting of millions of individual
cells-the result of which is that transcript quantiﬁcation represents the average signal across the cell
population being studied. Recent developments to isolate single cells, and barcode their expressed
transcripts has enabled the transcriptomes of single cells to be sequenced (scRNA-seq) in a high-
throughput manner. By sequencing large number of single cells from an individual ‘sample’ it is now
possible to dissect the cellular composition of apparently homogenous tissues or cell cultures11–13.
sc-RNAseq also opens the possibility of examining rare cell populations that could not otherwise be resolved
using bulk RNA-seq, and further characterising well-known cell types, for example oligodendrocytes14 or
sensory neurons15. Moreover, scRNA-seq may also be used for tracking cell lineage during differentiation, as
movement between different cell types is associated with changes in gene expression. Thus, stages across a
cell lineage can be distinguished by their unique transcriptional signature16. This technology has also been
used in cell culture, in particular with PSCs, their differentiated progeny and organoids, including of the
nervous system17,18, as a way to distinctively characterize cellular subpopulations. Results of such analyses
can discern determinants of cell fates, and this information can then applied to in vitro differentiation
experiments to increase efﬁciency of generating the tissue of interest19.
Retinal ganglion cells (RGCs) transmit visual information from the retina to the midbrain through the
optic nerve. Many diseases, such as primary open angle glaucoma, Leber hereditary optic neuropathy and
autosomal dominant optic atrophy manifest by degeneration or loss of RGCs and culminate in
irreversible loss of sight. It is estimated that there are more than 30 subtypes of RGCs in the mammalian
retina20, however, the molecular proﬁling of RGCs in human normal and disease tissue has proven
difﬁcult. Currently, studying optic neuropathies is hindered by the lack of non-invasive means for
obtaining RGCs from living donors. This can now be circumvented by use of PSCs as a source of RGCs8.
We recently described a protocol for the differentiation of human PSCs into functional RGCs7. RGCs
generated through this method are functional, as exempliﬁed by the presence of sodium and potassium
currents, mature axon potentials and the expression of RGC-speciﬁc markers, including BRN3B, ISL1 and
PRPH7. Moreover, whole transcriptome analysis through bulk RNA-seq of our PSC-derived RGCs
demonstrated close resemblance to sensory neurons, and cells from the ganglion cell layer7. Herein we
present a dataset of scRNA-seq to characterize the transcriptome of RGCs derived from human ESCs
(hESCs) at a single cell level.
Methods
Ethical approval
All experimental work performed in this study was approved by the Human Research Ethics committees
of the University of Melbourne (0605017) with the requirements of the National Health & Medical
Research Council of Australia (NHMRC) and conformed with the Declarations of Helsinki.
Cell culture and retinal differentiation
The hESC BRN3B-mCherry reporter line (A81-H7),9 was maintained on vitronectin-coated 6-well plates
using StemFlex (Gibco). Culture medium was changed every second day. Cells were differentiated into
RGCs as previously described7. Brieﬂy, undifferentiated hESCs cultured in monolayer on vitronectin-
coated plates were differentiated using RGC differentiation medium 2 (DMEM F12 with GlutaMAX, 10%
KnockOut Serum Replacement (Invitrogen), SM1 (Stem Cell Tech), 10 ng/ml noggin (Sapphire
Biosciences), 10 ng/ml Dickkopf-related protein 1 (DKK1, Peprotech), 10 ng/ml Insulin Growth Factor 1
(IGF1, Peprotech) and 5 ng/ml basic Fibroblast Growth Factor (bFGF, Merck). Medium was changed
every 2–3 days. RGC differentiation was monitored by the appearance of mCherry-positive cells,
reﬂective of BRN3B expression.
Fluorescence-activated cell sorting (FACS)
On day 36 of differentiation, cells were washed with phosphate-buffered saline (PBS) and incubated with
Accutase (Sigma, 37 °C, 5 min). Cells were then incubated in RGC differentiation medium supplemented
with the ROCK inhibitor Y27632 (10 μM, Selleckchem, RGC+RI) and gently dissociated using a P1000
pipette, ﬁltered using a 100 μm nylon strainer (BD Falcon) and centrifuged (300 g, 10 min). The cell pellet
was resuspended in RGC+RI medium and incubated with THY1 antibody (Human THY1 FITC
conjugated, Miltenyi, 130-095-403, 4 °C, 15 min). Cells were washed in RGC+RI medium, and
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centrifuged (300 g, 3 min). Two modiﬁcations to our original protocol were performed. Firstly, selection
of RGCs using THY1 was performed by FACS instead of the magnetic sorting we originally reported.
Secondly, cells were prepared for sequencing immediately following THY1 selection and were not allowed
to rest prior to being further processed. A cell pellet was resuspended in 500 μl of RGC+RI prior to
sorting with a BD FACSAria III cell sorter (Becton, Dickinson). Both THY1-positive (+ve) and THY1-
negative (-ve) fractions were collected in 5 ml conical tubes (BD Falcon).
Single-cell preparation
Both THY1-positive (+ve) and THY1-negative (-ve) fractions were subjected to library preparation using
the Single Cell 3′ Reagent Kit (10X Genomics) as per the manufacturer’s instruction. This step was
performed within 60 min of the FACS. Brieﬂy, cell suspension was mixed using a wide-bore tip to
determine cell concentration using a Countess® Automated Cell Counter (Life Technologies). Cells were
centrifuged for 5 min at 300 g and the cell pellet was resuspended in PBS with 0.04% BSA. The cell
suspension was passed through a cell strainer to remove any remaining cell debris and large clumps and
the cell concentration was determined again.
Generation of single cell GEMs and sequencing libraries
Single cell suspensions were loaded onto 10X Genomics Single Cell 3′ Chips along with the reverse
transcription (RT) master mix as per the manufacturer's protocol for the Chromium Single Cell 3′ v2
Library (10X Genomics; PN-120233), to generate single cell gel beads in emulsion (GEMs). Sequencing
libraries were generated with unique sample indices (SI) for each sample. The resulting libraries were
assessed by gel electrophoresis (Agilent D1000 ScreenTape Assay) and quantiﬁed with qPCR (Illumina
KAPA Library Quantiﬁcation Kit). Following normalization to 2 nM, libraries were denatured and
diluted to 17pM of cluster generation using the Illumina cBot (HiSeq PE Cluster Kit v4). Libraries for the
two samples were multiplexed respectively, and sequenced on an Illumina HiSeq 2500 (control software
v2.2.68/ Real Time Analysis v1.18.66.3) using a HiSeq SBS Kit v4 (Illumina, FC-401-4003) in high-output
mode as follows: 126 bp (Read 1), 8 bp (i7 Index), 8 bp (i5 Index), and 126 bp (Read 2).
Mapping of reads to transcripts and cells
The sequencing data was processed into transcript count tables with the Cell Ranger Single Cell Software
Suite 1.3.1 by 10X Genomics (http://10xgenomics.com/). Raw base call ﬁles from the HiSeq2500
sequencer were demultiplexed with the cellranger mkfastq pipeline into library-speciﬁc FASTQ ﬁles. As
the libraries were sequenced using non-standard settings, cellranger mkfastq was run with the following
parameters: --use-bases-mask= "Y26n*,I8n*,n*,Y98n*" --ignore-dual-index. The FASTQ ﬁles for each
library were then processed independently with the cellranger count pipeline. This pipeline used STAR21
to align cDNA reads to the Homo sapiens transcriptome (Sequence: GRCh38, Annotation: Gencode v25).
Once aligned, barcodes associated with these reads – cell identiﬁers and Unique Molecular Identiﬁers
(UMIs), underwent ﬁltering and correction. Reads associated with retained barcodes were quantiﬁed and
used to build a transcript count table. Resulting data for each sample were then aggregated using the
cellranger aggr pipeline, which performed a between-sample normalization step and concatenated the two
transcript count tables. Post-aggregation, the mapped data was processed and analyzed as
described below.
Preprocessing
To preprocess the mapped data, we constructed a cell quality matrix based on the following data types:
library size (total mapped reads), total number of genes detected, percent of reads mapped to
mitochondrial genes, and percent of reads mapped to ribosomal genes. Cells that had any of the 4
parameter measurements lower than 3x median absolute deviation (MAD) of all cells were considered
outliers and removed from subsequent analysis (Table 1)22. In addition, we applied two thresholds to
remove cells with mitochondrial reads above 20% or ribosomal reads above 50% (Table 1). To exclude
genes that were potentially detected from random noise, we removed genes that were detected in fewer
than 1% of all cells. The expression data was normalised on two levels to reduce possible systematic bias
between samples and between cells. The ﬁrst level of normalisation - between samples, was performed
prior to data aggregation using the cellranger aggr depth equalisation method23. This method reduces
potential confounding effects caused by differences in sequencing depths between samples by
subsampling mapped reads from higher-depth libraries until the number of mapped reads per library
were equal. The second level of normalisation - between cells, was performed after ﬁltering using the
deconvolution approach by Lun et al.24. This level of normalisation reduces bias possibly caused by
technical variation such as cDNA synthesis, PCR ampliﬁcation efﬁciency and sequencing depth for each
cell. The deconvolution approach was chosen as it accounts for the sparse nature of expression data by
pooling expression counts from groups of cells. As the sizes of the groups were linear (40, 60, 80, 100), the
group-speciﬁc normalised size factors could be deconvolved into cell-speciﬁc size factors that were then
used to scale the counts of individual cells. After normalisation, abundantly expressed ribosomal protein
genes and mitochondrial genes were discarded. We have made available both the raw and normalised
data (Data Citation 1).
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Identiﬁcation of residual low-quality cells via clustering
We identiﬁed and removed a small group of cells with low-quality sequence data. These cells were not
detected by initial ﬁltering; instead, they were identiﬁed via clustering and enrichment of differentially
expressed genes. The transcript count table underwent dimensionality reduction using Principal
Component Analysis (PCA). This procedure was applied to the top 1,500 most variable genes using the
prcomp() function in R25. The ﬁrst 20 PCs were retained and a cell-PCA eigenvector matrix was used for
clustering.
We applied an unsupervised clustering method that does not take into account any predetermined
parameters to objectively identify single cell subpopulations26. This method is less biased compared to
top-down clustering approaches, such as k-means. Brieﬂy, to achieve high-resolution clustering capable
of detecting small subpopulations and outliers, we applied bottom-up agglomerative hierarchical
clustering to construct a dendrogram tree, where the highest resolution is one cell= one bottom branch.
We used the reduced dataset containing the top 20 PCs described above to calculate an Euclidean
distance matrix between cells, and organized cells into the dendrogram using the Ward’s minimum
distance so that similar cells are joint into larger groups of branches. To identify subpopulations, we
applied an unsupervised, objective approach to merge the branches into a high-resolution and stable
clustering result. The approach divided the dendrogram tree into 40 height-windows, ranging from 0.025
(from the bottom of the tree) to 1 (from the top). By iteratively and dynamically merging cells in each of
the 40 height-windows, we generated 40 independent clustering results with varying resolutions.
Clustering results were then compared quantitatively using adjusted Rand indices, which score pairs of
cells that are the same or different between two clustering results27. The optimal clustering result was the
most stable result across a range of consecutive tree-height values.
Sample Number of
cells
Median reads
per cell
Median genes
per cell
Total genes
detected
Median UMIs
per cell
Total number of
reads
Percent
mapped reads
Remaining cells post
ﬁltering
1 1,090 124,127 3,528 21,317 13,575 135,299,096 61.10 993
2 194 493,659 5,188 19,812 26,218 95,769,921 62.80 181
Table 1. Summary statistics for sequencing and mapping data of two samples.
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Figure 1. Schematic representation of the experimental workﬂow. (a) Guided differentiation of the reporter
line BRN3B-mCherry A81-H7 hESCs into RGCs using IGF1, DKK1, Noggin, bFGF in a neural medium
containing SM1 and N2, as described in Ref. 7. On day (d) 36, cells were sorted based on the expression of the
marker THY1. Cells from both positive and negative THY fractions were then processed for scRNA-seq.
Brightﬁeld images describe cell morphology of undifferentiated hESCs prior to differentiation (d0) and post
differentiation (d36) at time of sorting. (b) Single cell suspensions are prepared and libraries generated using
the Chromium V2 chemistry. Libraries were sequenced on an Illumina HiSeq2500. (c) Sequence data is
processed using bioinformatic pipelines, and analysis conducted on the resulting expression matrix.
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To characterise the identiﬁed clusters, we performed pairwise differential expression analysis by ﬁtting
a general linear model and using a negative binomial test as described in the DESeq package28. Network
analysis was then performed on signiﬁcant differentially-expressed genes using Reactome functional
interaction analysis28,29.
Code availability
All code and usage notes are available at: https://github.com/IMB-Computational-Genomics-Lab/
RetinaGanglionCells. This includes: computational bioinformatic pipelines that process sequence data in
BCL format through to a mapped UMI expression matrix; scripts for quality-control, normalisation,
clustering, differential expression and visualization.
Data Records
Data is available at ArrayExpress under accession number: E-MTAB-6108. Files consist of raw FASTQ
ﬁles as well as a tab separated matrix of Transcripts Per Million for each cell passing quality control
ﬁltering. BAM ﬁles can be generated by using the supplied repository to process the FASTQ ﬁles via Cell
Ranger.
Technical Validation
The hESC reporter line BRN3B-mCherry A81-H7 was differentiated to RGCs following our established
protocol7, changing culture medium every second day. After 36 days, selection of RGCs using THY1 was
performed by FACS. Both positive and negative THY fractions were harvested, and single cells harvested
for library preparation and scRNA-Seq as outlined in Fig. 1. Processing our initial analysis identiﬁed a
group of 61 cells whose expression levels indicated degradation and apoptosis (Fig. 2a and b). These 61
cells were removed from the data and the expression data from the remaining 1,174 healthy cells was re-
normalised and analysed. Clustering of these 1,174 cells identiﬁed three distinct subpopulations
consisting of 531, 355 and 288 cells (Fig. 3a). We performed differential expression analysis and
subsequently pathway enrichment to characterise the molecular functions of these subpopulations (Fig.
3b-g). The proportion of reads mapped to mitochondrial and ribosomal genes are displayed in Fig. 4.
The 531 cells from subpopulation one were upregulated for genes associated with neural cell adhesion
molecule signalling for neuronal outgrowth and Hedgehog pathway, which plays various roles in
patterning of the central nervous system. Interestingly, genes implicated in collagen biosynthesis,
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Figure 2. Identiﬁcation of residual low-quality cells via clustering. (a) Unsupervised clustering of all cells
into two subpopulations. The dendrogram tree displays distance and agglomerative clustering of the cells. Each
branch represents one subpopulation. The clustering is based on the most stable clustering result across 40 tree
cut heights. The branches are labelled with their subpopulation identiﬁcation. The number of cells in each of
the two populations are given below the branches. (b) The top signiﬁcantly expressed genes at the initial
ﬁltering step between Cluster 1 and 2 shows upregulation of genes associated with apoptosis in Cluster 2.
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288 355 531
Figure 3. Characterisation of ﬁltered cells via differential expression. (a) Unsupervised clustering of cells
after ﬁltering into three subpopulations. The dendrogram tree displays distance and agglomerative clustering of
the cells. Each branch represents one subpopulation. The clustering is based on the most stable clustering result
across 40 tree cut heights. The branches are labelled with their subpopulation identiﬁcation. The numbers of
cells in each of the three populations are given below the branches. The top signiﬁcantly expressed genes of cells
of each cluster vs other clusters; (b) one vs two and three, (c) two vs one and three, (d) three vs one and two.
The top signiﬁcantly expressed genes of cells in subpopulation one vs two (e), one vs three (f), two vs three (g).
Genes represented in blue and black points are those in the top 0.5% highest -log(P-value). Genes represented
by red points are related to apoptotic pathways.
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Figure 4. Percentage of reads that mapped to mitochondrial and ribosomal transcripts.
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Figure 5. Cell heterogeneity within the RGC population using the PCA analysis. Shown are PC1 (x axis) vs
PC2 (y axis) scores of cells from three clusters. (a) Cells from cluster 1 are plotted in red, cluster 2 in blue and
cluster 3 in green. Relative expression of genes characteristic for the RGC subtypes: (b) THY1 (thymocyte
antigen 1, CD90), (c) DRD4 (Dopamine receptor D4), (d) TRH (Thyrotropin-releasing hormone), (e) CDH6
(Cadherin-6), (f) PAX6 (Paired box 6), (g) SDK2 (Protein sidekick-2), (h) JAM2 (Junctional adhesion molecule
B), (i) PVALB (Parvalbumin), (j) TYW3 (TRNA-YW synthesizing protein 3), (k) SPP1 (Secreted
phosphoprotein 1, Osteopontin), (l) OPN4 (Melanopsin).
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extracellular matrix proteoglycans and axon guidance were downregulated (Supplementary Table S1,
Data Citation 2). This pattern of gene expression suggests a progenitor or an early differentiation state.
Cells from subpopulation two contained upregulated genes associated with control of the Notch protein
expression, implicated in the neuronal function and development, and DNA repair (Supplementary Table
S2, Data Citation 2). Collectively, this pattern of gene expression is indicative of a more differentiated
RGC phenotype than the cells in cluster one. The 288 cells identiﬁed as subpopulation three contained
upregulated genes involved in axon guidance, together with semaphorin interactions, cell-extracellular
matrix interactions and extracellular matrix proteoglycans. Furthermore, we observed signiﬁcant
downregulation of multiple genes associated with cell cycle (Supplementary Table S3, Data Citation 2).
Taken together this indicates that this subpopulation three represents a more mature neuronal phenotype
compared to cells in the other two subpopulations. Of note, one cell within subpopulation one was found
to express OPN4 a gene known to be expressed in intrinsically-photosensitive RGCs. These data indicate
different levels of maturity of ESC derived RGC, with this conclusion supported by observed pathway
enrichment (Supplementary Table S4-6, Data Citation 2). We have also conducted differential expression
and pathway enrichment analysis to explore expression of genes associated with different RGC subtypes.
In our analysis, we identiﬁed a number of genes that were previously shown to be expressed in various
RGC subpopulations (Fig. 5). These genes could mark at least 9 separate RGC subtypes that grouped into
three clusters30. This discrepancy may be explained by the fact that the number of RGC subtypes was
estimated based on their morphological features but also expression of the molecular markers, including
cell surface protein THY1, transcription factors from the Brn (Pou4F) family and RNA-binding protein
RBPMS30. In our experimental design, we included the RGC enrichment step by sorting differentiated
cells for THY17. Limitation of this approach is exclusion of cells that could have the RGC identity without
THY1 expression; however, we chose this marker as it is the cell surface protein and thus allows the
maintenance of live cells in culture prior to sequencing or further characterisation.
Usage Notes
Our experiment was designed to assess the different subpopulations of RGCs post differentiation from
hESCs. hESC-derived RGCs obtained in a 36- day guided differentiation clustered into distinct
subpopulations of neurons. Our initial analysis identiﬁed a group of 61 cells that showed a strong
enrichment of stress and apoptosis pathways. This is possibly due to the FACS procedure itself, which can
be stressful on cells. All post quality-control cells express genes relevant to RGC structure and functions.
Altogether, our data provides strong support of an RGC identity of the cells in all clusters.
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